STAT5B and acute myeloid leukemia: Overall, these data demonstrate that the synergistic effects of AC-4–130-mediated STAT5 inhibition together with the inhibition of other pathways are of potential therapeutic value and reveal new mechanistic insights into the role STAT5 signaling in AML.